首页> 外文期刊>Obstetrical and gynecological survey >Vaginal Progesterone, Oral Progesterone, 17-OHPC, Cerclage, and Pessary for Preventing Preterm Birth in At-Risk Singleton Pregnancies: An Updated Systematic Review and Network Meta-analysis
【24h】

Vaginal Progesterone, Oral Progesterone, 17-OHPC, Cerclage, and Pessary for Preventing Preterm Birth in At-Risk Singleton Pregnancies: An Updated Systematic Review and Network Meta-analysis

机译:阴道黄体酮,口服孕酮,17-OHPC,CERLAGE和PERENARY用于预防风险的早产Singleton怀孕:更新的系统审查和网络META分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Around the world, approximately 15 million pregnancies each year end in preterm birth (before 37 weeks' gestation), a major contributor to child morbidity and mortality. To reduce the risk of preterm birth for women at increased risk, interventions include progesterone, cervical cerclage, and cervical pessary. Previous studies concluded that progesterone (especially natural progesterone) was the best intervention to prevent preterm birth and neonatal death in women at risk and in women with a previous preterm birth. The researchers sought to update this meta-analysis comparing the 3 interventions' effectiveness in preventing pretermbirth at-risk women, women with a previous pretermbirth, and women with a short cervix, separating progesterone by administration.
机译:世界各地,每年约1500万次怀孕,早产(在37周之前的妊娠之前),是儿童发病率和死亡率的主要贡献者。 为了降低妇女增加风险增加的早产的风险,干预措施包括孕酮,宫颈塞尔格和宫颈露头。 以前的研究得出结论,孕酮(特别是天然孕酮)是预防患有预防性和以前早产的女性的早产和新生儿死亡的最佳干预。 研究人员试图更新该荟萃分析,比较3个干预措施在预防危险性妇女的预防性妇女的3种干预措施,女性患有以前的早产儿的女性,并且通过管理分离孕酮的女性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号